Consistent with these clinical observations, we previously found that a Trp53-deficient mouse model of NF1-related MPNST exhibited faster tumor growth and was more resistant to chemotherapy compared to Trp53-intact models. The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.